FILE PHOTO: A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California (Reuters) - Illumina said on Tuesday it has partnered with the Broad Institute to ...
Research institutes are projected to capture 50% of total market revenue in 2025, reflecting their pivotal role in genomic innovation. These institutions rely heavily on high-throughput sequencing ...
Eight years ago, 10x Genomics launched the first commercially available single-cell RNA sequencing (scRNA-seq) product for the company’s flagship instrument, the 10x Chromium. (This occurred one year ...
Zymo Research, a global leader in the field of epigenetics, microbiomics and transcriptomics, proudly announces the launch of its latest innovation, the Zymo-Seq™ SPLAT DNA Library Kit. This ...
Several studies have been published linking epigenetic mechanisms to gene functions in cancer, autoimmune disease, as well as biological processes like aging. With the release of the EpiFinder family ...
Key market opportunities in mutation detection kits for genome editing include addressing rising genetic disorders with ...
With the Chromatin Immunoprecipitation Testing market projected to double by 2035, the message for manufacturers is clear: ...
5don MSN
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
What if a single test could simultaneously contribute to the diagnosis, characterization, and treatment guidance of childhood ...
Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...
Aug 13 (Reuters) - Illumina (ILMN.O), opens new tab said on Tuesday it has partnered with the Broad Institute to develop new kits that will allow large-scale gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback